Concepedia

Takako Yanai

TY

Statistics

Publications

4

Citations

391

H-Index

4

Active since

2006

Affiliations

National Cancer Center(Current)

National Cancer Centre Japan

Osaka City General Hospital

Chiba University

Japanese Foundation For Cancer Research

Takako Yanai is an author at National Cancer Center specializing in pharmacology, chemotherapy, and pharmacotherapy.

Publications per year

2006–2017

4

Publications

4

Heparin Potentiates the in Vivo Ectopic Bone Formation Induced by Bone Morphogenetic Protein-2

Baohong Zhao, Takenobu Katagiri, Hiromitsu Toyoda et al. · Journal of Biological Chemistry · 2006 · 278 citations · Full text

, , +14

A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy

Takako Yanai, Satoru Iwasa, Hironobu Hashimoto et al. · International Journal of Clinical Oncology · 2017 · 75 citations

, , +12

Successful rechallenge for oxaliplatin hypersensitivity reactions in patients with metastatic colorectal cancer.

Takako Yanai, Satoru Iwasa, Hirhonobu Hashimoto et al. · PubMed · 2012 · 27 citations

, , +15

A double-blind randomized phase II study of 10 versus 5 mg olanzapine for emesis induced by highly emetogenic chemotherapy with cisplatin.

Hironobu Hashimoto, Takako Yanai, Kengo Nagashima et al. · Journal of Clinical Oncology · 2016 · 11 citations

, , +15

1–4 of 4